POLYCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION POSSESSING PROPERTY OF H3 RECEPTOR ANTAGONIST AND METHOD FOR TREATMENT BY ITS USING

FIELD: organic chemistry, medicine, pharmacy. ^ SUBSTANCE: invention relates to novel polycyclic compounds of the formula (I): wherein radicals and symbols have values given in the invention claim. Compounds of the formula (I) possess properties of H3 receptors antagonist. Also, invention relates to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MANGIARASINA P'ETRO, BOJS KRISTOFER V, ASLANJAN ROBERT DZH, MAK KORMIK KEVIN D, ROZENBLJUM STJUART B, SHIKH NENG-JANG, TING POULIN K, TOM VING K, BERLIN MAJKL J, MUTAKHI MVANGI VA, PIVINSKI DZHON DZH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: organic chemistry, medicine, pharmacy. ^ SUBSTANCE: invention relates to novel polycyclic compounds of the formula (I): wherein radicals and symbols have values given in the invention claim. Compounds of the formula (I) possess properties of H3 receptors antagonist. Also, invention relates to a pharmaceutical composition containing compounds of the formula (I). Also, invention relates to a method for treatment of disease of group comprising difficulty in nasal breath, obesity, somnolence, narcolepsy, attention deficiency with hyperactivity, Alzheimer's disease and schizophrenia that involves using compounds of the formula (I) and, optionally, in combination of H receptor antagonist. ^ EFFECT: valuable medicinal properties of compound and pharmaceutical composition. ^ 39 cl, 3 tbl, 31 ex